Definitive Healthcare Corp (DH)
NASDAQ:DH
Want to see DH full AI Analyst Report?
DH Stock Chart & Stats
$1.03
-$0.06(-1.41%)
At close: 4:00 PM EST
$1.03
-$0.06(-1.41%)
Day’s Range― - ―
52-Week Range$0.80 - $4.70
Previous CloseN/A
Volume69.97K
Average Volume (3M)338.90K
Market Cap
$122.50M
Enterprise Value$102.12M
Total Cash (Recent Filing)$178.09M
Total Debt (Recent Filing)$169.84M
Price to Earnings (P/E)―
Beta1.59
Next Earnings
Aug 12, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.62
Shares Outstanding105,524,240
10 Day Avg. Volume311,870
30 Day Avg. Volume338,897
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.26
Enterprise Value/Market Cap0.83
Enterprise Value/Revenue0.43
Enterprise Value/Gross Profit0.59
Enterprise Value/Ebitda8.80
Forecast
1Y Price Target
$2.51Price Target Upside144.11% Upside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)0.18
Revenue Forecast (FY)$223.61M
Bulls Say, Bears Say
Bulls Say
Customer Retention ImprovementImproved gross revenue retention and a meaningful rise in gross dollar retention indicate the customer base is stabilizing, which could make revenue more predictable and support a valuation re-rating if sustained.
Financial Results And Investor CommunicationReported revenue and adjusted profitability exceeded expectations and CFO engagement at a major investor conference underscores management's focus on transparent communication, which could boost investor confidence.
Product And Data EnhancementsPlatform innovations, the addition of a new claims data source, and diversification of data providers have improved data quality and expanded integrations, increasing appeal to enterprise clients and supporting potential upsell opportunities.
Bears Say
Fixed-cost Pressure And Weak GuidanceA high fixed-cost structure combined with forward guidance below analysts' consensus increases pressure on profitability and could magnify downside if revenue growth remains sluggish.
Revenue Decline And Turnaround UncertaintyRevenue is declining and management expects further decreases, leaving the timing of a sustainable turnaround unclear and creating downside risk for the stock.
Weak Upsell And Resumed ChurnWeak upsell and cross-sell performance, coupled with resumed customer churn after renewals, limits organic growth and threatens progress on net dollar retention.
Definitive Healthcare Corp News
DH FAQ
What was Definitive Healthcare Corp’s price range in the past 12 months?
Definitive Healthcare Corp lowest stock price was $0.80 and its highest was $4.70 in the past 12 months.
What is Definitive Healthcare Corp’s market cap?
Definitive Healthcare Corp’s market cap is $122.50M.
When is Definitive Healthcare Corp’s upcoming earnings report date?
Definitive Healthcare Corp’s upcoming earnings report date is Aug 12, 2026 which is in 79 days.
How were Definitive Healthcare Corp’s earnings last quarter?
Definitive Healthcare Corp released its earnings results on May 07, 2026. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.033 by $0.027.
Is Definitive Healthcare Corp overvalued?
According to Wall Street analysts Definitive Healthcare Corp’s price is currently Undervalued.
Does Definitive Healthcare Corp pay dividends?
Definitive Healthcare Corp does not currently pay dividends.
What is Definitive Healthcare Corp’s EPS estimate?
Definitive Healthcare Corp’s EPS estimate is 0.04.
How many shares outstanding does Definitive Healthcare Corp have?
Definitive Healthcare Corp has 105,524,240 shares outstanding.
What happened to Definitive Healthcare Corp’s price movement after its last earnings report?
Definitive Healthcare Corp reported an EPS of $0.06 in its last earnings report, beating expectations of $0.033. Following the earnings report the stock price went up 3.254%.
Which hedge fund is a major shareholder of Definitive Healthcare Corp?
Currently, no hedge funds are holding shares in DH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Definitive Healthcare Corp Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2.51 (144.11% Upside)
$2.51 (144.11% Upside)
Hedge Fund Trend
Decreased
By 85.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.79%
12-Months-Change
Fundamentals
Return on Equity
-67.07%
Trailing 12-Months
Asset Growth
-36.35%
Trailing 12-Months
Company Description
Definitive Healthcare Corp
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
DH Company Deck
DH Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed but constructive picture: near-term top-line pressures persist, driven by the life sciences segment and a shift to shorter-duration deals (reflected in declines in revenue, deferred revenue, and RPO). Offsetting these headwinds are stronger-than-expected profitability and margin expansion, solid cash generation (~$50M trailing FCF), meaningful operational progress on data quality (claims remediation), faster and more numerous integrations, professional services acceleration (+25% YoY), and a clear AI/innovation roadmap that management expects will drive improved retention and future monetization. The company beat guidance on profit metrics and is maintaining full-year targets while investing in strategic initiatives to return to growth, but material execution is still required to translate operational improvements into sustained top-line growth.View all DH earnings summariesDH Stock 12 Month Forecast
Average Price Target
$2.51
▲(144.11% Upside)
Technical Analysis
Ownership Overview
11.64% Insiders
4.07% Mutual Funds
61.17% Other Institutional Investors
17.71% Public Companies and
Individual Investors